摘要
目的:探讨米非司酮(R u486)、甲氨蝶呤(M TX)及两者联合治疗异位妊娠的临床疗效。方法:将68例早期诊断为异位妊娠且符合保守治疗条件的病例随机分为3组:A组28例,甲氨蝶呤50 m g单次肌肉注射;B组22例,米非司酮50 m g,口服,每日2次,用3 d;C组18例,米非司酮50 m g,口服,每日2次,用2 d,然后肌肉注射甲氨蝶呤40m g。结果:A组治愈19例,治愈率为68%;B组治愈16例,治愈率为72%;C组治愈15例,治愈率83%。A、B两组比较差异无显著性(P>0.05);C组疗效优于A、B组(P<0.05);血-βHCG转阴时间A、B、C组分别为(21.4±8.3)d、(20.6±7.8)d、(15.2±6.8)d,A、B两组比较差异无显著性(P>0.05);C组短于A、B组(P<0.05);三组均无肝肾功能损害病例。结论:采用R u486及M TX联合用药治疗异位妊娠疗程短,疗效高,优于单一用药。
Objective:To probe the clinical therapeutic effect of mifepristone(Ru486),Methotrexate(MTX)and therapeutic alliance in ectopie pregnancy. Methods:Sixty-eight early ectopic pregnancy cases approving for conservative therapy were in random divided into three groups:group A 28 cases:MTX 50 mg,single intramuscular injection (im) ;group B 22 cases :Ru486 50 mg was used for oral twice in a day ,for 3 days ,group C 18 cases :Ru486 50 mg was used for oral twice in a day,for 2 days ,then MTX 40 mg,im. Rusults :The curing cases were respectively 19,16 and 15 cases in group A,B and C. The cure rate were 68%,72% and 83%. There was no difference between group A and B (P〉0. 05). The clinical effect of group C was more better than group A and B(P〈0. 05). The darkening time of β- HCG in blood in three groups were(21.4±8.3) d, (20. 6±7.8) d and (15. 2±6.8) d. There was no significant difference between group A and B(P〉0.05), The time of group C was shorter than group A and B(P〈0. 05). There were no damage of liver and renal function in three groups. Conelution : The therapeutic alliance of Ru486 and MTX in ectopic pregnancy has short course of treatment and hypsicurative effect. It is better than single medication.
出处
《临床医药实践》
2006年第12期889-891,共3页
Proceeding of Clinical Medicine